Features | Partner Sites | Information | LinkXpress
Sign In
BioConferenceLive
JIB
GLOBETECH PUBLISHING

Single-Use Bioreactor Now Accommodates Wide Range of Working Volumes

By BiotechDaily International staff writers
Posted on 24 Jun 2013
Image: The UniVessel SU (right) can work in parallel with classical multiuse reaction bioreactor vessels (Photo courtesy of Sartorius Stedim Biotech).
Image: The UniVessel SU (right) can work in parallel with classical multiuse reaction bioreactor vessels (Photo courtesy of Sartorius Stedim Biotech).
Image: The UniVessel SU is preassembled and ready-to-use out of the box (Photo courtesy of Sartorius Stedim Biotech).
Image: The UniVessel SU is preassembled and ready-to-use out of the box (Photo courtesy of Sartorius Stedim Biotech).
The second generation of a highly regarded single-use bioreactor vessel with built-in pH and dissolved oxygen sensors suitable for work with mammalian, insect, and plant cell cultures was recently released for researchers in biopharmaceuticals and other life sciences.

The Sartorius Stedim Biotech (Aubagne, France) UniVessel SU is a single-use bioreactor with a choice of working volumes ranging from 0.6 to two liters. The vessel is made of USP class VI conforming polycarbonate and includes several ports for media addition, sampling, harvesting, as well as spare ports for insertion of classical sensors or other equipment. All tubing for media transfer is thermoweldable and features common Luer or MPC connectors for fast and easy connection to peripheral equipment.

Key features of the UniVessel SU are the single-use sensors for optical measurement of pH and dissolved oxygen (DO). The determination of pH and DO with the SENSOLUX system is based on fluorescence detection. Each UniVessel SU contains two sensor patches for pH and DO, respectively. The actual measurement is performed optically and noninvasively from outside the vessel. The sensor patches contain fluorescent dyes, which can be excited with light of a given wavelength. Optoelectronics integrated in the vessel holder transmit light of a particular wavelength to the sensor patches. In turn, they also transmit the luminescence response from the patches to a measuring amplifier. The sensor patches inside the UniVessel SU come precalibrated. Calibration data are located on the vessel label and can be transferred manually or by barcode reader to the calibration menu of the bioreactor controller. UniVessel SU is compatible with Sartorius BIOSTAT controllers and can also be operated with nearly any other brand of bioreactor controller.

Each UniVessel SU unit is irradiated prior to delivery and is preassembled and ready-to-use out of the box. It is designed to the same safety standards, which are required for classical multiuse bioreactors. The complete culture vessel is disposed after use, eliminating cleaning time, autoclaving, and reinstallation hassle as well as the risk of cross-contamination.

Related Links:
Sartorius Stedim Biotech




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.